These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 35415210)
1. Characterization of cerebrospinal fluid biomarkers associated with neurodegenerative diseases in healthy cynomolgus and rhesus macaque monkeys. Robertson EL; Boehnke SE; Lyra E Silva NM; Armitage-Brown B; Winterborn A; Cook DJ; De Felice FG; Munoz DP Alzheimers Dement (N Y); 2022; 8(1):e12289. PubMed ID: 35415210 [TBL] [Abstract][Full Text] [Related]
2. The effect of lumbar puncture on the neurodegeneration biomarker neurofilament light in macaque monkeys. Boehnke SE; Robertson EL; Armitage-Brown B; Wither RG; Lyra E Silva NM; Winterborn A; Levy R; Cook DJ; De Felice FG; Munoz DP Alzheimers Dement (Amst); 2020; 12(1):e12069. PubMed ID: 32695873 [TBL] [Abstract][Full Text] [Related]
3. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus. Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890 [TBL] [Abstract][Full Text] [Related]
4. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study. Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350 [TBL] [Abstract][Full Text] [Related]
5. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China. Jiao B; Liu H; Guo L; Liao X; Zhou Y; Weng L; Xiao X; Zhou L; Wang X; Jiang Y; Yang Q; Zhu Y; Zhou L; Zhang W; Wang J; Yan X; Tang B; Shen L Front Aging Neurosci; 2021; 13():749649. PubMed ID: 34776933 [No Abstract] [Full Text] [Related]
17. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease. Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586 [TBL] [Abstract][Full Text] [Related]
18. Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up. Bruzova M; Rusina R; Stejskalova Z; Matej R Sci Rep; 2021 May; 11(1):10837. PubMed ID: 34035398 [TBL] [Abstract][Full Text] [Related]
19. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice. Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902 [TBL] [Abstract][Full Text] [Related]
20. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment. Kern S; Syrjanen JA; Blennow K; Zetterberg H; Skoog I; Waern M; Hagen CE; van Harten AC; Knopman DS; Jack CR; Petersen RC; Mielke MM JAMA Neurol; 2019 Feb; 76(2):187-193. PubMed ID: 30419087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]